Lactulose and Nicorette drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lactulose (lactulose) and Nicorette (nicotine polacrilex). Common drug interactions include weight increased among females and neoplasm malignant among males.

The phase IV clinical study analyzes what interactions people have when they take Lactulose and Nicorette. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Lactulose?

Lactulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 46,960 Lactulose users. Check the latest studies of Lactulose.

What is Nicorette?

Nicorette has active ingredients of nicotine polacrilex. It is often used in quit smoking. eHealthMe is studying from 18,484 Nicorette users. Check the latest studies of Nicorette.



On Jul, 30, 2026

42 people who take Lactulose and Nicorette together, and have interactions are studied.

Lactulose and Nicorette drug interactions.

What are the common drug interactions of Lactulose and Nicorette, by gender? *:

female:

  1. Weight increased
  2. Arthralgia (joint pain)
  3. Back pain
  4. Headache (pain in head)
  5. Oedema peripheral (superficial swelling)
  6. Pain
  7. Rash
  8. Skin infection
  9. Abscess oral (abscess in the mouth)
  10. Eosinophil count decreased

male:

  1. Neoplasm malignant (cancer tumour)
  2. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  3. Renal failure acute (rapid kidney dysfunction)
  4. Swollen tongue (swelling of tongue)

What are the common drug interactions of Lactulose and Nicorette, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Eosinophil count decreased
  2. Haemoglobin decreased
  3. Haemorrhage (bleeding)
  4. Intentional self-injury
  5. Mean cell haemoglobin concentration decreased (less concentration of haemoglobin in a given volume of packed red blood cells)
  6. Mean cell volume increased (more than normal average red blood cell volume)
  7. Red blood cell count decreased
  8. Arthralgia (joint pain)
  9. Blood alkaline phosphatase increased
  10. Drug exposure during pregnancy

30-39:

  1. Drug screen false positive

40-49:

  1. Pickwickian syndrome (extreme obesity accompanied by sleepiness, hypoventilation, and polycythemia)
  2. Dyspnoea (difficult or laboured respiration)
  3. Weight increased
  4. Asthma

50-59:

  1. Impaired gastric emptying
  2. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  3. Anaemia (lack of blood)
  4. Back pain
  5. Depression
  6. Gun shot wound
  7. Hospitalisation
  8. Hot flush (sudden feelings of heat)
  9. Hypokalaemia (low potassium)
  10. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)

60+:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Neoplasm malignant (cancer tumour)
  3. Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
  4. Oesophagitis (inflammation of oesophagus)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Osteonecrosis of jaw (death of bone of jaw)
  7. Postoperative wound complication
  8. Abscess oral (abscess in the mouth)
  9. Mouth ulceration (mouth ulcers)
  10. Chest discomfort

What are the existing conditions these people have? *

  1. Agitation (state of anxiety or nervous excitement): 15 people, 35.71%
  2. Pain: 14 people, 33.33%
  3. Stress And Anxiety: 11 people, 26.19%
  4. Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 11 people, 26.19%
  5. Depressive Symptom: 11 people, 26.19%
  6. Affective Disorder (mental disorder): 11 people, 26.19%
  7. Irritable Bowel Syndrome: 11 people, 26.19%
  8. Depression: 9 people, 21.43%
  9. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 8 people, 19.05%
  10. Insomnia (sleeplessness): 7 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Lactulose and Nicorette?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lactulose and Nicorette:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lactulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nicorette:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lactulose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nicorette and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lactulose and nicotine polacrilex (the active ingredients of Lactulose and Nicorette, respectively), and Lactulose and Nicorette (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: